Early research (Phase 1)UnknownNCT04756934What this trial is testingHX008 Plus LP002 for the Treatment of Patients With Advanced MelanomaWho this might be right forMelanoma Taizhou HoudeAoke Biomedical Co., Ltd. 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773363What this trial is testingRetlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic CancerWho this might be right forPancreatic Cancer Tang-Du Hospital 37
Testing effectiveness (Phase 2)UnknownNCT05007938What this trial is testingBefotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung CancerWho this might be right forNon-Small Cell Lung Cancer Betta Pharmaceuticals Co., Ltd. 30
Early research (Phase 1)Looking for participantsNCT07660432What this trial is testingSIM0689 in Adult Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forNeoplasms, Malignant Jiangsu Simcere Pharmaceutical Co., Ltd. 472
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461181What this trial is testingEvaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Ruijin Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02723877What this trial is testingPQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)Who this might be right forMetastatic Breast Cancer PIQUR Therapeutics AG 41
Large-scale testing (Phase 3)UnknownNCT03048877What this trial is testingEfficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer Peking Union Medical College Hospital 118
Early research (Phase 1)Active Not RecruitingNCT05160545What this trial is testingGNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 36
Testing effectiveness (Phase 2)UnknownNCT06308939What this trial is testingEribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical TrialWho this might be right forMetastatic Breast Cancer Zhejiang Cancer Hospital 81
Large-scale testing (Phase 3)Looking for participantsNCT06452277What this trial is testingLearn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Who this might be right forAdvanced Non-small Cell Lung Cancer, HER2 Mutation Bayer 555
Testing effectiveness (Phase 2)Ended earlyNCT04267120What this trial is testingLenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)Who this might be right forRenal Cell Carcinoma Washington University School of Medicine 11
Early research (Phase 1)Study completedNCT04341259What this trial is testingThe Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors.Who this might be right forSolid Tumors Hoffmann-La Roche 12
Testing effectiveness (Phase 2)Study completedNCT00054145What this trial is testingPerifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast CancerWho this might be right forBreast Cancer University Health Network, Toronto
Testing effectiveness (Phase 2)Temporarily pausedNCT07042295What this trial is testingTreatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune SystemWho this might be right forLocally Recurrent Skin Squamous Cell CarcinomaMetastatic Skin Squamous Cell Carcinoma National Cancer Institute (NCI) 86
Large-scale testing (Phase 3)Active Not RecruitingNCT06316531What this trial is testingA Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerWho this might be right forHER2-positive Breast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 274
Not applicableLooking for participantsNCT06902545What this trial is testingObserve the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.Who this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Korea, Inc.
Testing effectiveness (Phase 2)UnknownNCT04718701What this trial is testingAnlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic CancerWho this might be right forPancreatic NeoplasmMetastatic Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma The First Affiliated Hospital with Nanjing Medical University 53
Early research (Phase 1)Study completedNCT03260322What this trial is testingA Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Astellas Pharma Global Development, Inc. 169
Large-scale testing (Phase 3)Looking for participantsNCT03592472What this trial is testingPazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)Who this might be right forRenal Cell Carcinoma Xynomic Pharmaceuticals, Inc. 413
Early research (Phase 1)Study completedNCT00622622What this trial is testingGemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Wakayama Medical University 21